Claritev Corp

CTEV

Market cap $238M

SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Claritev Corporation (NYSE: CTEV). The investigation focuses on Claritev's executive officers and whether investor losses may be recovered under federal securities laws.

Claritev Corporation (CTEV) Q4 2025 Earnings Call Prepared Remarks Transcript

Claritev Corporation (CTEV) came out with a quarterly loss of $4.88 per share versus the Zacks Consensus Estimate of a loss of $3.96. This compares to a loss of $5.14 per share a year ago.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the fourth quarter and full year ended December 31, 2025. “I am exceedingly proud of the work delivered by the Claritev team in 2025. This year marked a pivotal time in our company's history, as we returned to top line revenue growth highlighted by op.

MCLEAN, Va--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its fourth quarter and fiscal year 2025 financial results after market close on Monday, February 23, 2026, and hold a conference call at 4:30 pm Eastern Time. To join the conference call, please pre-register using the link below. Participant.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent, and fair for all, today announced a strategic relationship with Kinetiq Health, a healthcare risk management organization specializing in claims surveillance, diagnostic certainty, and cost intervention strategies. Rising medical and pharmacy costs are often driven by a small number of complex, high-cost.

Claritev Corporation (CTEV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced its participation in the 44th Annual J.P. Morgan Healthcare Conference. Management will be presenting on Thursday, January 15, 2026 at 7:30 a.m. PT. A live webcast and audio archive of the presentation will be available through the investor relations section of Claritev's.

Claritev Corporation (CTEV) Presents at Bank of America Leveraged Finance Conference Transcript

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Announces Participation at Upcoming Conferences.